•
BF
BFRIW
Biofrontera Inc. Warrants
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
--
Volume
101.00
52W High
$0.28
52W Low
$0.03
Open
$0.00
Prev Close
$0.05
Day Range
0.00 - 0.00
About Biofrontera Inc. Warrants
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Latest News
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
GlobeNewswire Inc.•Dec 4
Biofrontera Q2 Revenue Jumps 15%
The Motley Fool•Aug 14
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire Inc.•Aug 13
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
GlobeNewswire Inc.•Aug 4
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
GlobeNewswire Inc.•Jun 11
Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis
GlobeNewswire Inc.•May 1
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
GlobeNewswire Inc.•Mar 21
Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.•Nov 13